Klinikum der Universität München (LMU Klinikum)

Development of a national strategy with recommendations for the care of seriously ill and dying people and their relatives in pandemics: A modified Delphi study (2022) Gauder S, Pralong A, Remi C, Hodiamont F, Klinger I, Heckel M, Simon ST, Bausewein C Journal article Early Outcome, Cosmetic Result and Tolerability of an IOERT-Boost Prior to Adjuvant Whole-Breast Irradiation (2022) Jazmati D, Bölke E, Halfmann K, Tamaskovics B, Ruckhäberle E, Fehm T, Hoffmann J, et al. Journal article Predictive Factors of Long-Term Survival after Neoadjuvant Radiotherapy and Chemotherapy in High-Risk Breast Cancer (2022) Haussmann J, Budach W, Nestle-Krämling C, Wollandt S, Tamaskovics B, Corradini S, Bölke E, et al. Journal article Evaluation of an anthropomorphic ion chamber and 3D gel dosimetry head phantom at a 0.35 T MR-linac using separate 1.5 T MR-scanners for gel readout (2022) Nierer L, Kamp F, Reiner M, Corradini S, Rabe M, Dietrich O, Parodi K, et al. Journal article Mid-term treatment-related cognitive sequelae in glioma patients (2022) Schlömer S, Felsberg J, Pertz M, Hentschel B, Löffler M, Schackert G, Krex D, et al. Journal article Initial and repeat reactions in the European Anaphylaxis Registry a comparative analysis (2022) Hoefer V, Doelle-Bierke S, Rueff F, Hartmann K, Pfoehler C, Treudler R, Wagner N, Worm M Conference contribution Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis-Results from the Adjuvant SUCCESS A Trial (2022) Trapp EK, Fasching P, Fehm T, Schneeweiss A, Mueller V, Harbeck N, Lorenz R, et al. Journal article Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist's Decision on Systemic Therapy in a Real-World Setting (2022) Erber R, Angeloni M, Stöhr R, Lux MP, Ulbrich-Gebauer D, Pelz E, Bankfalvi A, et al. Journal article Immuntherapie bei neuroendokrinen Tumoren: Zeitpunkt und Zielgruppe (2022) Auernhammer CJ, Pavel ME Journal article Improved pasireotide response in USP8 mutant corticotroph tumours in vitro (2022) Albani A, Perez-Rivas LG, Tang S, Simon J, Lucia KE, Colón-Bolea P, Schopohl J, et al. Journal article